Acute Myeloid Leukemia (AML) With
specificAcute myeloid leukemia characterized by the presence of a FLT3-internal tandem duplication (ITD) mutation. Patients with this mutation usually present with more aggressive disease and have higher rates of relapse after remission.
22
Centers
0
Active Trials
$4M
Cancer Funding
Top Centers for Acute Myeloid Leukemia (AML) With(22)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →